Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2008 Sep;1(5):561–568. doi: 10.1016/j.jcmg.2008.04.013

Table 1.

Baseline Characteristics

CRT-HF Cohort (n=20) Multimodality Cohort (n=27)
Age, mean (SD), y 58 ± 10 50 ± 15
Gender, No. (%)
 Male 13 (65) 16 (59)
 Female 7 (35) 11 (41)
Cardiomyopathy, No. (%)
 Ischemic 8 (40) 8 (30)
 Nonischemic 12 (60) 19 (70)
LVEF, mean (SD) 0.23 (0.057) 0.20 (0.066)
QRSd, mean (SD), ms 151 (26) 138 (34)
NYHA Class, No. (%)
 I 0 (0) 3 (11)
 II 0 (0) 12 (44)
 III 20 (100) 12 (44)
 IV 0 (0) 0 (0)
Medication use, No. (%)
 Beta Blocker 19 (90) 26 (96)
 Amiodarone 3 (15) 1 (4)

CRT-HF=Cardiac Resynchronization Therapy-Heart Failure

LVEF=left ventricular ejection fraction

QRSd = QRS duration

NYHA=New York Heart Association